BTW
RMD icon

Boston Trust Walden’s ResMed RMD Stock Holding History

Boston Trust Walden’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,450
Closed -$225K – 371
2019
Q4 		$225K Buy
+1,450
New +$209K ﹤0.01% 371
2019
Q3 		– Sell
-68,965
Closed -$8.42M – 384
2019
Q2 		$8.42M Buy
68,965
+203
+0.3% +$22.5K 0.11% 204
2019
Q1 		$7.15M Sell
68,762
-41,448
-38% -$4.28M 0.1% 209
2018
Q4 		$12.5M Sell
110,210
-17,430
-14% -$1.87M 0.2% 150
2018
Q3 		$14.7M Buy
127,640
+3,198
+3% +$350K 0.2% 139
2018
Q2 		$12.9M Buy
124,442
+1,988
+2% +$201K 0.19% 153
2018
Q1 		$12.1M Sell
122,454
-707
-0.6% -$66.8K 0.18% 158
2017
Q4 		$10.4M Buy
123,161
+5,308
+5% +$439K 0.15% 179
2017
Q3 		$9.07M Buy
117,853
+811
+0.7% +$62K 0.14% 192
2017
Q2 		$9.11M Buy
117,042
+5,156
+5% +$369K 0.15% 176
2017
Q1 		$8.05M Sell
111,886
-1,590
-1% -$110K 0.13% 191
2016
Q4 		$7.04M Sell
113,476
-7,898
-7% -$484K 0.11% 202
2016
Q3 		$7.86M Sell
121,374
-1,094
-0.9% -$72.8K 0.13% 189
2016
Q2 		$7.74M Buy
122,468
+18,782
+18% +$1.11M 0.13% 190
2016
Q1 		$6M Buy
103,686
+34,614
+50% +$1.96M 0.1% 209
2015
Q4 		$3.71M Buy
69,072
+2,460
+4% +$139K 0.07% 227
2015
Q3 		$3.39M Buy
66,612
+440
+0.7% +$23.7K 0.06% 240
2015
Q2 		$3.73M Buy
66,172
+45,922
+227% +$2.9M 0.06% 233
2015
Q1 		$1.45M Sell
20,250
-100
-0.5% -$6.5K 0.02% 263
2014
Q4 		$1.14M Hold
20,350
– – 0.02% 279
2014
Q3 		$1M Buy
20,350
+150
+0.7% +$7.64K 0.02% 283
2014
Q2 		$1.02M Sell
20,200
-50
-0.2% -$2.48K 0.01% 277
2014
Q1 		$905K Buy
20,250
+5,250
+35% +$236K 0.01% 264
2013
Q4 		$706K Sell
15,000
-84,578
-85% -$4.28M 0.01% 278
2013
Q3 		$5.26M Buy
99,578
+850
+0.9% +$41.2K 0.08% 197
2013
Q2 		$4.46M Buy
+98,728
New +$4.68M 0.07% 197

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Trust Walden's RMD Position: Q1 2020 in Review

Boston Trust Walden sold out of ResMed (RMD) in Q1 2020, closing a stake of 1,450 shares — an estimated $225K sold.

Boston Trust Walden first reported a position in RMD in Q2 2013 and held it in 26 quarters. The position peaked at $14.7M in Q3 2018. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • Boston Trust Walden reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • Boston Trust Walden sold 1,450 ResMed shares in Q1 2020, an estimated $225K.
  • Boston Trust Walden first reported a position in ResMed in Q2 2013 and held it in 26 quarters.
  • Boston Trust Walden's ResMed position peaked at $14.7M in Q3 2018.
  • 584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Boston Trust Walden's 13F filing for Q1 2020, filed 21 Apr 2020.